Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier.
When a shortage of brand-name weight-loss drugs like Ozempic and Wegovy cleared the way for companies like Hims to fill the gap with cheaper, compounded versions, customers came flocking. But in February, the US Food and Drug Administration announced the shortage was over, leaving the company's strategy in flux and some investors worried. On today’s Big Take podcast, host David Gura and Bloomberg healthcare reporter Madison Muller track how Hims became the king of copycat weight-loss drugs and what’s next for the company as it fights to hold onto the crown. Read more: How Hims Became the King of Knockoff Weight-Loss Drugs Cheap Ozempic Knockoffs Are Suddenly Everywhere. Are They Safe? The Weight-Loss Drug Boom’s Prescription Problem Listen and follow The Big Take on Apple Podcasts, Spotify or wherever you get your podcasts.See omnystudio.com/listener for privacy information.
--------
15:03
--------
15:03
Why Trump Is Letting Nvidia Sell (Some) AI Chips to China
In an unusual deal, Nvidia and Advanced Micro Devices have agreed to pay the US government 15% of their revenue from AI chips they sell to China. The US has blocked the sale of other, more powerful chips to China on the basis of national security, but the exception underscores the Trump administration’s openness to make exceptions… if the price is right. On today’s Big Take podcast, Bloomberg economic statecraft reporter Joe Deaux joins host Sarah Holder to explain the unprecedented nature of the deal, concerns about its legality and how it fits into Trump’s approach to trade with global competitors.See omnystudio.com/listener for privacy information.
--------
18:49
--------
18:49
What’s at Stake Ahead of Trump-Putin Meeting
President Donald Trump is heading to Alaska to host a face-to-face meeting with his Russian counterpart, Vladimir Putin to talk about finally, maybe, putting an end to Russia’s war with Ukraine. Notably not invited? Ukraine — or any other European leaders. Today on the show, Bloomberg editor Flavia Krause-Jackson joins host David Gura to talk about why Russia has finally agreed to talk, what’s likely to be on the table in Anchorage and how significant this summit might be.See omnystudio.com/listener for privacy information.
--------
18:10
--------
18:10
How China Is Bringing Hong Kong’s IPO Market Back to Life
After a years-long slump, Hong Kong’s IPO market is roaring back to life, thanks to a growing number of Chinese companies that are raising billions of dollars in the city. On today’s Big Take Asia Podcast, host K. Oanh Ha and Bloomberg’s Dave Sebastian explore how China is transforming the financial hub into a key funding engine for mainland firms— and the risks this poses for banks on Wall Street and beyond.See omnystudio.com/listener for privacy information.
--------
14:41
--------
14:41
Who’s Really Paying for Tariffs? Hint: It’s Not Foreign Companies
President Trump’s so-called reciprocal tariffs have pushed the average US tariff rate to 15%, up from just over 2% last year. But who’s actually footing the bill so far? On today’s Big Take podcast, Bloomberg Businessweek’s “Everybody’s Business” host Stacey Vanek Smith takes Sarah Holder through Tariff 101: How is that money being collected and where is it going? Read more: It’s Only a Matter of Time Until Americans Pay for Trump’s TariffsSee omnystudio.com/listener for privacy information.
The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.
México